Company researchers developed cardiac ablation technology that mimics the navigation system of electric fish.
Scientists have studied electric fish for decades to determine how and why they discharge electricity.
Recently, a couple of biomedical engineers at Boston Scientific realized that the way these fish use their electrical impulses to navigate around hazards could apply to treating atrial fibrillation (AF).
The result is DirectSense technology, which the company uses in its Intellanav MiFi open-irrigated (OI) ablation catheter to measure local impedance — or the amount of resistance — in the tissue to the electrical current that the catheter is applying.
Get the full story on our sister site, Medical Tubing + Extrusion